Skip to main content
. 2022 May 22;14(5):1106. doi: 10.3390/pharmaceutics14051106

Figure 3.

Figure 3

Boron accumulation in B16F10 melanoma (a) and plasma (b), and melanoma to plasma ratio of boron accumulation (c) of 3-BPA-Fru and 4-BPA-Fru at 10, 30, 60, and 120 min after administration.